A Switch Study of BMS-337039 in Schizophrenic Out-patients
Clinical trial NCT00232687 · COMPLETED
Trial details
- NCT number
- NCT00232687
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2007-04-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.